BioCentury
ARTICLE | Clinical News

Sepracor, HMR regulatory update

October 30, 1995 8:00 AM UTC

Hoechst filed an NDA for terfenadine carboxylate, an active metabolite of the FDA-approved drug terfenadine, which the pharma company sells in the U.S. as Seldane. The event marks the first NDA filed ...